Literature DB >> 17008331

A novel autosomal recessive limb-girdle muscular dystrophy with quadriceps atrophy maps to 11p13-p12.

J Jarry1, M F Rioux, V Bolduc, Y Robitaille, V Khoury, I Thiffault, M Tétreault, L Loisel, J P Bouchard, B Brais.   

Abstract

Limb-girdle muscular dystrophies (LGMD) are a heterogeneous group of pathologies. We have identified a cohort of 14 French-Canadian patients from eight different families displaying a novel form of LGMD with an autosomal recessive inheritance. These patients share some features with previously described cases of 'quadriceps myopathy' that evolved into an LGMD. All demonstrate quadriceps femoris asymmetrical atrophy. Creatine kinase values were variable from normal to 6000 U/l. Clinical evaluations and MRI studies demonstrate a variable intrafamilial and interfamilial phenotype. Asymmetrical muscle involvement was clinically observed and confirmed by imaging. MRI studies suggest that the hamstrings and the adductor magnus are the first limb muscles to demonstrate fatty infiltration. Muscle pathology shows no sign of active inflammation but increased endomysial connective tissue associated with basal lamina duplication and collagen disorganization. A genome-wide scan using the two largest families uncovered linkage to marker D11S1360 on chromosome 11p12 [multipoint logarithm of the odds (LOD) score of 2.78]. Further genotyping for the eight families confirmed linkage to this new LGMD locus (multipoint LOD score of 4.56). Fine mapping subsequently defined a less than 3.3 cM candidate interval on 11p13-p12. Haplotype analysis of carrier chromosomes suggests that the most frequent mutation may account for up to 81.3% of French-Canadian mutations. In this study, we describe the chromosomal locus of a new form of recessive LGMD with prominent quadriceps femoris atrophy.

Entities:  

Mesh:

Year:  2006        PMID: 17008331     DOI: 10.1093/brain/awl270

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  18 in total

1.  Myopathy caused by anoctamin 5 mutations and necrotizing vasculitis.

Authors:  Isabelle Pénisson-Besnier; Jean-Paul Saint-André; Debbie Hicks; Anna Sarkozy; Anne Croué; Judith Hudson; Hanns Lochmüller; Frédéric Dubas
Journal:  J Neurol       Date:  2012-04-19       Impact factor: 4.849

2.  Quadriceps myopathy caused by skeletal muscle-specific ablation of β(cyto)-actin.

Authors:  Kurt W Prins; Jarrod A Call; Dawn A Lowe; James M Ervasti
Journal:  J Cell Sci       Date:  2011-02-15       Impact factor: 5.285

3.  Novel diagnostic features of dysferlinopathies.

Authors:  Xiomara Q Rosales; Julie M Gastier-Foster; Sarah Lewis; Malik Vinod; Devon L Thrush; Caroline Astbury; Robert Pyatt; Shalini Reshmi; Zarife Sahenk; Jerry R Mendell
Journal:  Muscle Nerve       Date:  2010-07       Impact factor: 3.217

Review 4.  Anoctamins/TMEM16 Proteins: Chloride Channels Flirting with Lipids and Extracellular Vesicles.

Authors:  Jarred M Whitlock; H Criss Hartzell
Journal:  Annu Rev Physiol       Date:  2016-11-16       Impact factor: 19.318

5.  A new distal myopathy with mutation in anoctamin 5.

Authors:  Ibrahim Mahjneh; Jyoti Jaiswal; Antti Lamminen; Mirja Somer; Gareth Marlow; Sari Kiuru-Enari; Rumaisa Bashir
Journal:  Neuromuscul Disord       Date:  2010-08-07       Impact factor: 4.296

6.  Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies.

Authors:  Véronique Bolduc; Gareth Marlow; Kym M Boycott; Khalil Saleki; Hiroshi Inoue; Johan Kroon; Mitsuo Itakura; Yves Robitaille; Lucie Parent; Frank Baas; Kuniko Mizuta; Nobuyuki Kamata; Isabelle Richard; Wim H J P Linssen; Ibrahim Mahjneh; Marianne de Visser; Rumaisa Bashir; Bernard Brais
Journal:  Am J Hum Genet       Date:  2010-01-21       Impact factor: 11.025

7.  Candidate-gene testing for orphan limb-girdle muscular dystrophies.

Authors:  S Aurino; G Piluso; V Saccone; M Cacciottolo; F D'Amico; M Dionisi; A Totaro; A Belsito; U Di Vicino; V Nigro
Journal:  Acta Myol       Date:  2008-12

Review 8.  Limb-girdle muscular dystrophies - international collaborations for translational research.

Authors:  Rachel Thompson; Volker Straub
Journal:  Nat Rev Neurol       Date:  2016-04-01       Impact factor: 42.937

9.  A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy.

Authors:  Debbie Hicks; Anna Sarkozy; Nuria Muelas; Katrin Köehler; Angela Huebner; Gavin Hudson; Patrick F Chinnery; Rita Barresi; Michelle Eagle; Tuomo Polvikoski; Geraldine Bailey; James Miller; Aleksander Radunovic; Paul J Hughes; Richard Roberts; Sabine Krause; Maggie C Walter; Steven H Laval; Volker Straub; Hanns Lochmüller; Kate Bushby
Journal:  Brain       Date:  2011-01       Impact factor: 13.501

10.  Frequency and characterisation of anoctamin 5 mutations in a cohort of Italian limb-girdle muscular dystrophy patients.

Authors:  Francesca Magri; Roberto Del Bo; Maria Grazia D'Angelo; Monica Sciacco; Sandra Gandossini; Alessandra Govoni; Laura Napoli; Patrizia Ciscato; Francesco Fortunato; Erika Brighina; Sara Bonato; Andreina Bordoni; Valeria Lucchini; Stefania Corti; Maurizio Moggio; Nereo Bresolin; Giacomo Pietro Comi
Journal:  Neuromuscul Disord       Date:  2012-06-27       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.